MIAMI, June 22, 2017 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ:OPK) today announced that the Kidney Disease Improving Global Outcomes (KDIGO) organization has updated its Clinical Practice ...

Most individuals with chronic kidney disease (CKD) are unaware of their disease, according to a KDIGO controversies conference on CKD prevention.

Medically reviewed by Robert Burakoff, MD The five stages of chronic kidney disease (CKD) indicate how well the kidneys are working, ranging from stage 1 (mild kidney damage) to stage 5 (kidney ...

The proportions of CKD patients requiring BP-lowering treatment were 53.7% per the 2012 KDIGO guideline, 60.4% per the 2017 ACC/AHA guideline and 66.1% per the 2021 KDIGO guideline, according to ...

Similarly, 17.8% of those with stage G1-A2 CKD, 44% of those with stage G2-A2 and 61.3% of those with stage G3a-A1 CKD patients progressed to a higher KDIGO risk category.

Most patients with undiagnosed CKD had stage 3 (82%). Compared with CKD patients with a diagnosis, those who went undiagnosed were more often female (63% vs 45%) and white (78% vs 72%).